Professional
Added to YB: 2024-05-30
Pitch date: 2024-05-23
SRT3.DE [bullish]
Sartorius Aktiengesellschaft
-11.26%
current return
Author Info
No bio for this author
Company Info
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products.
Market Cap
EUR 14.5B
Pitch Price
EUR 255.36
Price Target
N/A
Dividend
0.31%
EV/EBITDA
20.60
P/E
N/A
EV/Sales
5.45
Sector
Life Sciences Tools and Services
Category
growth
RGA Investment Advisors Portfolio Holding: Sartorius Aktiengesellschaft
SRT3.DE: Sartorius is a pure-play bioprocessing leader with a comprehensive portfolio, especially in single-use bioreactors. Strong customer relationships and reliable service drive market share gains. Despite higher growth, now trades at a rare discount to peer Danaher, offering an attractive entry point for this industry leader.
Read full article (3 min)